OzUK at DDL 2025 Supporting the Global Transition to Next Generation pMDI Propellants

Drug Delivery to the Lungs 2025 | December 11-13 | Edinburgh International Conference Centre

OzUK is heading to DDL 2025 to meet partners, collaborators, and innovators across inhaled drug delivery. We will be discussing our ATEX rated pMDI lowGWP pilot plant and our end to end capability in generic and novel pressurised metered dose inhaler development. With the global transition to low GWP propellants now accelerating, our team is actively supporting reformulation, stability, spray characterisation, scale up, and regulatory ready CMC packages for next generation pMDIs. If you are planning your HFA to low GWP transition or developing a new pMDI product, we welcome the opportunity to connect and discuss how OzUK can support your program.

Connect with us at DDL to discuss your pMDI development needs through the conference app